UNTERNEHMENSDATEN
Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc. …
KURSVERLAUF
1T
+5 %
1W
-10 %
1M
-6,5 %
6M
-8,5 %
YTD
-19,8 %
1J
+12,8 %
2J
+60,9 %
5J
+322,3 %
10J
+916 %
FRAG DIE AGENTEN ZU HROW
Keine Anlageberatung. Für die vollständige Analyse-Übersicht: zur Analyse-Seite →
ANALYSTEN-EINSCHÄTZUNG
KURSZIEL TIEF
63,00 $
KONSENS
73,67 $
MEDIAN
70,00 $
KURSZIEL HOCH
88,00 $
0
STRONG BUY
10
BUY
0
HOLD
0
SELL
0
STRONG SELL
10
GESAMT · Buy
| DATUM | ANALYSTENHAUS | RATING | AKTION |
|---|---|---|---|
| 21.07.2026 | BTIG | Buy | maintain |
| 13.05.2026 | Cantor Fitzgerald | Overweight | maintain |
| 12.05.2026 | BTIG | Buy | maintain |
| 17.04.2026 | BTIG | Buy | maintain |
| 07.04.2026 | B. Riley Securities | Buy | maintain |
| 19.03.2026 | HC Wainwright & Co. | Buy | maintain |
| 18.03.2026 | BTIG | Buy | maintain |
| 04.03.2026 | Cantor Fitzgerald | Overweight | maintain |
KENNZAHLEN
KGV
-100,18
KBV
51
EV/EBITDA
53,13
EIGENKAPITALRENDITE
-96,2 %
NETTOMARGE
-62,4 %
VERSCHULDUNG (D/E)
10,47
DIVIDENDENRENDITE
0 %
STAND
31.03.2026
FREE FLOAT & LIQUIDITÄT
STREUBESITZ
75,9 %
AKTIEN IM STREUBESITZ
28.284.724
Ø TAGESVOLUMEN (30T)
716.814
INVESTIERTE FONDS
| FONDS / INSTITUTION | ANTEILE | VERÄNDERUNG | STAND |
|---|---|---|---|
| Westside Investment Management, Inc. | 224.051 | +38.125 | 30.06.2026 |
| Blackhawk Capital Partners LLC. | 203.241 | +30.909 | 30.06.2026 |
| WOODMONT INVESTMENT COUNSEL LLC | 111.810 | +1.251 | 30.06.2026 |
| EQUITABLE TRUST CO | 79.378 | +37.615 | 30.06.2026 |
| D.A. DAVIDSON & CO. | 34.650 | -1.886 | 30.06.2026 |
AKTIENSPLITS
| DATUM | VERHÄLTNIS |
|---|---|
| 08.02.2013 | 1:5 |
| 24.02.2012 | 1:8 |
| 28.09.2007 | 231:500 |
Keine Anlageberatung. Vergangene Wertentwicklung ist kein Indikator für zukünftige Ergebnisse.